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Background: Psychotherapy is an effective treatment for mental health disorders, but even with the most
efficacious treatment, many patients do not experience improvement. Moderator analysis can identify the
conditions under which treatment is effective or whether there are factors that can attenuate the effects of
treatment.
Methods: In this study, linear mixed model analysis was used to examine whether the Full Scale IQ (FSIQ),
Performance IQ (PIQ) and Verbal IQ (VIQ) on the Wechsler Intelligence Scale for Children – Third Edition, moderated
outcomes in general functioning and symptom load. A total of 132 patients treated at three outpatient child and
adolescent mental health services (CAMHS) were assessed at three different time points. The Children’s Global
Assessment Scale (CGAS) and the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA)
were used to measure the severity of impairments in general functioning and symptom load. IQ was assessed at
the start of treatment.
Results: Moderator analysis revealed that the FSIQ × time interaction predicted changes in CGAS scores (p< .01),
and that the PIQ × time interaction predicted changes in HoNOSCA scores (p< .05). The slopes and intercepts in
HoNOSCA scores covaried negatively and significantly (p< .05). The same pattern was not detected for the CGAS
scores (p = .08).
Conclusions: FISQ and PIQ moderated change in general functioning and symptom load, respectively. This implies
that patients with higher IQ scores had a steeper improvement slope than those with lower scores. The patients
with the highest initial symptom loads showed the greatest improvement, this pattern was not found in the
improvement of general functioning.Introduction
Numerous studies have shown that psychotherapy is an
efficacious treatment for mental health disorders among
children and adolescents [1], but even with the most
efficacious interventions, many patients do not experience
therapeutic improvement. In clinical decision-making,
the ability to recognise these patients is crucial when* Correspondence: borge.mathiassen@unn.no
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distribution, and reproduction in any mediumdetermining which type of psychotherapy a patient should
be offered. Moderator analysis, a method that can be
used to examine this question, can reveal the conditions
under which a treatment is effective or whether there are
factors that are attenuating the effects of treatment [2].
Examples of factors moderating the effects of therapy
are comorbidities, parental depression, a family’s need for
public assistance and gender [3,4]. Developmental factors
are recognised as a potentially important moderator of
psychotherapy, but few studies have used measures of
children’s and adolescents’ cognitive developmental levels
to examine whether they have a moderating effect [5].
Low IQ is a risk factor for mental health disorders.
Approximately one third of children with an intellectualtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Descriptive Data for the Total Sample
M M (SD; n)
HoNOSCA
Intake 12.35 (5.29; n= 128)
Assessment 11.11 (4.41; n= 118)
Follow-up 7.91 (4.34; n= 97)
CGAS
Intake 67.66 (11.17; n= 128)
Assessment 68.49 (10.22; n= 109)
Follow-up 75.28 (9.53; n= 94)
WISC-III IQ scores
FSIQ 84.77 (19.02; n= 132)
VIQ 83.81 (17.45; n= 132)
PIQ 89.52 (20.92; n= 132)
SDQ parent-rated
Emotional problems 3.38 (2.43; n= 132)
Conduct problems 2.33 (1.88; n= 132)
Hyperactivity 5.44 (2.86; n= 132)
Peer relationship problems 2.73 (2.04; n= 132)
Pro-social behaviour 7.58 (2.06; n= 132)
Total score 13.87 (5.84; n= 132)
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Australian children also showed that borderline intellec-
tual functioning (IQs in the range of 70–85) increased
the risk of mental health disorders [10]. In spite of the
finding that low IQ is a risk factor for mental health dis-
orders, only a small number of studies have investigated
whether patients’ IQs moderate the effects of therapy. In
a study of cognitively based treatment of children with
antisocial and aggressive behaviour, it was discovered
that low IQs predicted a worse outcome for girls but
not boys [11]. In the Multimodal Treatment Study of
Children with Attention Deficit/Hyperactivity Disorder
(ADHD), it was found that among children with severe
ADHD whose parents had depressive symptoms, those
with an IQ ≥ 100 responded better to both medical treat-
ment and combined medical and behavioural treatment
than those with an IQ< 100 [4].
The Health of the Nation Outcome Scales for Children
and Adolescents (HoNOSCA) [12] and the Children’s
Global Assessment Scale (CGAS) [13] are designed to
assess different aspects of children’s mental health status.
The HoNOSCA primarily measures symptom load,
whereas the CGAS measures general functioning. Scores
on the HoNOSCA and the CGAS are highly correlated
[14,15], indicating that they measure much of the same
construct. Several studies have found that both the
HoNOSCA [14,16,17] and the CGAS [18] are able to de-
tect changes in the mental health status of children with
mental health problems. A positive correlation has been
found between initial severity and changes in HoNOSCA
scores, indicating that higher initial severity predicts
larger changes in outcome [14,19].
Studies examining IQ as a predictor of HoNOSCA
and CGAS scores have yielded mixed results. The results
of a study of IQ as a predictor of HoNOSCA scores
showed that IQ predicted an additional 6 % of the vari-
ance after controlling for age and gender [20]. Results
from the same study revealed that IQ did not predict
CGAS scores. A correlation has been observed between
IQ and CGAS score among children admitted to a psy-
chiatric inpatient unit [21]. Furthermore, low IQ pre-
dicted CGAS scores in the clinical range in a study
comparing the offspring of depressed and non-depressed
parents [22]. In a study of youth with schizophrenia
and bipolar disorder at a psychiatric inpatient unit, no
significant associations were found between IQ and
HoNOSCA scores at admission or at follow up six years
later [23]. To our knowledge, no study has reported
whether a patient’s IQ moderates outcome in terms of
general functioning and symptom load as measured by
the CGAS and the HoNOSCA.
The objective of this study was to examine changes in
symptom load and general functioning in an outpatient
sample using the HoNOSCA and the CGAS as outcomemeasures. Participants were assessed with these instru-
ments at three different time points. We also examined
whether a patient’s cognitive functioning level (as
assessed with the Wechsler Intelligence Scale for Chil-
dren—Third Edition (WISC-III) IQ test) predicted
changes in HoNOSCA and CGAS scores over these time
points. We examined this relationship for both patients
on a waiting list and patients in active treatment. Based
on results from studies indicating that children with bor-
derline intellectual functioning have a significantly
increased risk for developing mental health problems
compared to normally developing peers [10,24], we
hypothesised that patients with higher IQ scores on the
WISC-III IQ scales Full Scale IQ (FSIQ), Performance
IQ (PIQ) and Verbal IQ (VIQ) would have better out-




The participants in this study (N= 132) were children
and adolescents treated at three outpatient child and
adolescent mental health services (CAMHS) in northern
Norway. All eligible patients were consecutively asked to
participate in the study. The mean age was 11.5 years
(SD= 2.4), 54.5 % (n= 72) of the sample was male and
45.5 % was female (n= 60). The clinical characteristics
of the participants are presented in Table 1. Classified
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Strength and Difficulties Questionnaire (SDQ) parent-
rated measure of children with symptoms of mental
health disorders in the abnormal/borderline range were
as follows: emotional problems 47.9 %, conduct problems
37.1 %, hyperactivity 51.5 %, peer relationship problems
54.5 %, and problems with pro-social behavior 18.2 %.
Measures
The Wechsler Intelligence Scale for Children—Third Edition
(WISC-III), Norwegian version [26], is an intelligence
test for children aged 6–16 years. The test consists of 13
subtests that are combined into three IQ scores: Full
Scale IQ (FSIQ), Verbal IQ (VIQ), and Performance IQ
(PIQ). Both the split-half and test-retest reliability of the
WISC-III IQ scores are high (rxx> .93) [27].
The Strengths and Difficulties Questionnaire (SDQ)
[28] is a behavioural screening questionnaire designed
for children and adolescents aged 3–16 years. It has
been widely used for research in the Nordic countries
[29]. There are separate SDQ forms for youths, parents
and teachers. In this study, the parent version was
used. Each form consists of 25 items divided into the fol-
lowing scales: emotional symptoms, conduct problems,
hyperactivity/inattention, peer relationship problems and
pro-social behaviour. The factor structure of the SDQ
has been replicated using confirmatory factor analysis in
a sample of Norwegian children [30].
The Children’s Global Assessment Scale (CGAS) [13] is
a rating scale that measures general functioning in chil-
dren aged 4–16 years with a range from 1 (needs con-
stant supervision) to 100 (superior functioning). The
most impaired level of functioning during the previous
month was rated. The CGAS has been evaluated in sev-
eral studies and is widely used to assess the severity of
mental health problems and outcomes [18,31]. A study
of inter-rater reliability [32] among clinicians working in
the Norwegian outpatient CAMHS revealed an intraclass
correlation coefficient (ICC) of .61. A similar ICC was
found in a comparable cross-national study [33].
The Health of the Nation Outcome Scales for Children
and Adolescents (HoNOSCA) [12] consists of 15 scales
that are rated from 0 (no problem) to 4 (severe to very
severe problem) by clinicians. In this study, only the first
13 scales were used, and the total score was used as a
measure of the overall severity of mental health pro-
blems (range 0–52). The HoNOSCA has been evaluated
in several studies and has been found to be easy to use,
reliable, valid and sensitive to change [14,16,17,32-34] A
study of inter-rater reliability [32] among clinicians
working in the Norwegian child and adolescent mental
health service revealed an ICC of .81, and in a compar-
able cross-national study [33], the ICC was found to
be .84.Procedures
The participants were assessed by clinicians using the
HoNOSCA and CGAS at three different time points: at
the intake session (T0), at the start of treatment (T1)
and after 6 months of treatment (T2) or at the end of
treatment if treatment lasted less than 6 months. The
mean waiting list time (the number of days from T0 to
T1) was 140.5 days (SD= 70.1), and the mean treatment
time (the number of days from T1 to T2) was 179.3 days
(SD= 71.4). The WISC-III assessment was performed
at T1.
There was some variation in the time at which the
parent SDQ was completed: 77.3 % (n= 102) of the
questionnaires were filled in at T1 and 33.7 % (n= 30) at
T0. Examinations of differences between the question-
naires completed at T0 and T1 were performed with in-
dependent sample t-tests independently for scales
measuring emotional symptoms, conduct problems,
hyperactivity/inattention, peer relationship problems and
pro-social behaviour. There was a small significant dif-
ference (t(130) = 2.59, p= .01, r= .22) between emotional
scales completed at T0 (M= 4.37, SD= 2.79) and T1
(M= 3.09, SD= 2.24). No significant differences were
found for the other scales.
This study was carried out in ordinary outpatient
clinics with an unscreened patient population. The
clinics had an eclectic approach to therapy and inter-
ventions, and were staffed with clinical psychologists,
child psychiatrists and social workers. Most of the
employees were specialist in their profession or under
specialization. The specialization programs for psycholo-
gist and physicians last for five years after six years of
university education, and includes compulsory seminars
and supervision from a specialist.
This study was approved by The Regional Committee
for Medical and Health Research Ethics, North Norway.
Statistical analyses
All statistical analyses were performed using SPSS version
16.0. Some participants assessed at the intake session had
missing data at later time points, and there were some
differences in assessment time points. Repeated measures
analyses of variance or regression analyses with dummy
variables would have necessitated the exclusion of partici-
pants with missing data. Additionally, these statistical
methods assume that all participants have been assessed
at the same time points. To overcome these problems,
linear mixed model analyses were used [35]. In a repeated
measures design analysed with linear mixed model statis-
tics, participants with missing data can be included in the
analysis, the time points of assessment can vary and it is
possible to specify the best variance-covariance structure
for the data [35]. The results can be interpreted in the
same way as a regression analysis results.
Table 2 Parameters in the final models with HoNOSCA





b SE b 95 % CI b SE b 95 % CI
FSIQ as moderator
Time −2,16** 0,26 −2.66,-1.64 −2.15 2.68 −7.47,3.17
FSIQ −0,07** 0,02 −0.10,-0.33 −0.07 0.07 −0.21,0.08
FSIQ × Time - - - 0.07* 0.03 0.01,0.13
PIQ as moderator
Time 0,30 1,11 −1.90,2.50 3,74** 0,59 2.57,4.91
PIQ −0,01 0,03 −0.07,0.05 0,10** 0,03 0.03,0.17
PIQ × Time −0,03* 0,01 −0.05,-0.00 - - -
VIQ as moderator
Time −2,15** 1,73 −2.67,-1.64 3,74** 0,59 2.57,4.91
VIQ −0,05 0,02 −0.09,-0.01 - - -
VIQ × Time - - - - - -
Note: * p< .05, ** p< .01.
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HoNOSCA and CGAS scores at different time points,
time was treated as a fixed factor. Bonferroni post-hoc
comparisons were used to adjust for multiple compari-
sons. The effect size of the different time points was
examined by calculating r based on the results from an
independent samples t-test. An interpretation of the effect
sizes was performed according to the guidelines suggested
by Cohen [36]. Effect sizes of r= .10 were interpreted as
small, r= .30 as moderate, and r= .50 as large.
The models examining repeated HoNOSCA and
CGAS measures, with the different WISC IQ scales as
moderator variables, were constructed in a stepwise
fashion. To test whether entering new variables into the
model increased the model fit, changes in −2 log likeli-
hood were used. The differences were examined with
chi-squared statistics. The first independent variable
entered in the model was time (the three time points)
and the next variable was the WISC IQ score. Entering
the different FSIQ-, PIQ- and VIQ-time interaction
terms as the final variable in the mixed-model analysis
was performed to examine the different WSIC IQ as
moderators. The repeated measures of HoNOSCA and
CGAS were entered at level 1 (data for individual
patients) in the model, whereas the different WISC IQ
scales were entered at level 2 (differences between
patients). Time and the IQ scales were treated as covari-
ates. An unstructured covariance structure was used.
Results
Characteristics of the sample
Of the 132 participants included in the study, 26.9 %
(n= 35) dropped out or had missing data before the final
HoNOSCA assessment was completed. We examined
whether the patients with missing data were different
from those with full data sets. To accomplish this, we
compared patients with and without HoNOSCA scores
at the final assessment with independent sample t-tests
examining the following variables: HoNOSCA and
CGAS score at the intake assessment, age, FSIQ, VIQ,
PIQ and mental health as measured by the SDQ ques-
tionnaire. An examination of differences in gender distri-
bution was performed with a Pearson chi-squared test.
There were no significant differences between the parti-
cipants with and without complete data from all assess-
ments. This result indicates that even though some of
the participants dropped out or had missing data after
the first assessment, the results from the final assess-
ment are representative of the whole sample.
Symptom load measured by HoNOSCA
The mean HoNOSCA scores for the three different time
points were significantly different (F(2, 340) = 24.60, p
< .01). Time predicted changes in HoNOSCA scores(b=−2.16, t(112.70) =−8.40, p< .01). The different
WISC IQ scores were examined in separate models. Nei-
ther entering the FSIQ×time (χ2 (1) = 2.04, p> .05) nor
the VIQ×time (χ2 (1) = 0.09, p> .01) interactions did
increased the model fit. Adding the PIQ×time inter-
action (χ2 (1) = 5.01, p< .05) did increase model fit, indi-
cating that PIQ moderated the outcome in HoNOSCA
scores. The interaction term PIQ × time predicted
changes in the HoNOSCA score (b=−0.03, t
(115.14) =−2.28, p= .02).The parameters of the final
model are presented in Table 2.
Post-hoc comparisons indicated that the mean HoN-
OSCA score at T0 (M=12.35, SD=5.29) was significantly
(p= .01) higher than that at T1 (M= 11.11, SD=4.42) and
that the score at T2 (M=7.91, SD= 4.42) was significantly
(p< .01) lower than that at T1. The effect size of the
reduction of HoNOSCA scores from T0 to T1 for the
whole sample was small and non-significant (r = .12;
t(237,78) = 1.95, p= .06), whereas the reduction from T1
to T2 was moderate (r= .34; t(209) = 5.17, p< .01).
The change in HoNOSCA scores across the three
time points showed a significant variance in intercepts
(var(u0j)=29.12, p< .01) but not in slopes (var(u1j)=2.30,
p= .06) across participants. The slopes and intercepts
covaried negatively and significantly (cov(u0j, u1j)=−7.14,
p= .01). This result indicates that the participants with
the highest initial HoNOSCA scores showed a greater
improvement across the time points compared to the
participants with the lowest scores.
General functioning measured by CGAS
The mean CGAS scores for the three different time points
were significantly different (F(2, 328) = 16.43, p< .01).
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t(104.11) = 6.33, p< .01). The different WISC IQ scores
were examined in separate models. Neither entering
the PIQ×time (χ2 (1) = 3.53, p> .05) or the VIQ×time
(χ2 (1) = 2.66, p> .01) interactions did increased model
fit. Adding the FSIQ×time interaction (χ2 (1) = 8.63,
p< .01) did increase model fit, indicating that FSIQ
moderated the outcome in CGAS scores. The interaction
term FSIQ × time predicted changes in the CGAS score
(b= 0.46, t(107.28) = 1.86, p< .01). The parameters of the
final model are presented in Table 2.
Post-hoc comparisons indicated that the mean CGAS
score at T0 (M= 67.66, SD= 11.17) was not significantly
(p = 1.00) different from that at T1 (M= 68.49, SD=
19.22) and that the score at T2 (M= 75.28, SD= 9.53)
was significantly (p< .01) higher than that at T1. The
effect size of the increase in CGAS from T1 to T2 was
moderate (r= .32; t(201) =−4.87, p< .01).
The change in CGAS scores across the three time points
showed significant variance in intercepts (var(u0j)=118.38,
p< .01) across participants. There was no significant vari-
ance in slopes (var(u1j)=9.02, p= .20) or in the covariation
between slopes and intercepts (cov(u0j, u1j)=−27.25,
p= .08).
Discussion
The main objective of this study was to examine if the
different WISC-III IQ scales moderates changes in symp-
tom load and general functioning among children and
adolescents referred to mental health outpatient clinics.
The results indicated that the patients’ symptom loads
and general functioning, as measured by HoNOSCA and
CGAS, respectively, improved for the entire sample.
Symptom load showed a decrease from the start of
treatment to the 6-month follow-up assessment, and the
effect size of this change was moderate. The patients
with the highest initial HoNOSCA scores showed the
greatest improvement. This result is consistent with pre-
vious research [14]. The results indicated that PIQ mod-
erated changes in HoNOSCA from the intake session to
the follow-up assessment, indicating that the improve-
ment slopes for patients with high PIQ were steeper
than those with lower PIQ. There were no gender differ-
ences in the moderating effect of PIQ. FSIQ and VIQ
did not moderate the outcome in HoNOSCA scores.
General functioning, as measured by the CGAS,
improved from the start of treatment to the 6-month
follow-up assessment. The effect size of this change was
moderate. There was no significant variance across the
participants in the intercept or slope of the change in
CGAS scores across the measurements performed at the
intake session, start of treatment or at the 6-month fol-
low-up assessment. The results indicated that FSIQ
moderated changes in CGAS scores and imply that thegeneral functioning improvement slope for patients with
high FSIQ were steeper than those with lower scores.
There were no gender differences in the moderating
effect of FSIQ. PIQ and VIQ did not moderate outcome.
In addition to psychometrical differences between the
HoNOSCA and CGAS scales, distinct properties of the
WISC-III IQ-scales may explain the differences in the
predictability of outcome. In addition to measuring dif-
ferent cognitive abilities, the heritability of the WISC-III
IQ-scales is dissimilar. The heritability of FSIQ, VIQ and
PIQ in early adolescent is 65 %, 51 % and 72 %, respect-
ively [37]. The environments influence the development
of the WISC-III IQ score in different ways. Common
environment influences on FSIQ, VIQ and PIQ in early
adolescent are 18 %, 26 % and 0 %, respectively [37].
Although the CGAS and the HoNOSCA measure dif-
ferent aspects of mental health impairment, there is a
large correlation between these measures [15]. This cor-
relation indicates that the CGAS and the HoNOSCA
measure much of the same psychological construct. In
our study different WISC-III IQ scales moderated the
outcome in general functioning measured and symptom
load measured with the CGAS and the HoNOSCA. This
difference could be explained by the different construc-
tion of the HoNOSCA and the CGAS. The HoNOSCA
total score is the sum of 13 scales, including one ques-
tion related to scholastic and language skills, which are
areas that have a high correlation with IQ [38], whereas
the CGAS consists of just one scale.
The identification of IQ as a moderator of changes in
general functioning and symptom load does not explain
the mechanism behind the relationship between IQ and
outcome. The cognitive reserve model has been pro-
posed as an explanation for the association between IQ
and the development of mental health disorders [25,39].
This model postulates that “cognitive reserve” (CR),
operationalized as, for example, education, occupational
attainment and IQ, is a proxy measure of brain reserve
capacity [40]. It could be that in addition to explaining
the increased risk for mental health disorders, the CR
model also explains why the patients in our study with
higher IQ scores had a larger improvement in general
functioning than the patients with lower scores. Because
IQ is associated with both brain size [41] and other
neuroanatomical and neurophysiological factors [38], it
could be that the patients with the largest cognitive
reserve had a greater capacity to benefit from the help
they received at the outpatient clinic.
Study limitations
The rate of dropout and missing data in this study was
26.5 %. Compared to other clinical studies, this was a
small dropout rate. A meta-analysis across 125 studies of
psychotherapy revealed a mean dropout rate of 46.9 %
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between the participants with complete and missing
data, there could potentially be relevant differences
between these groups that were not examined.
The main methodological strength of our study is that
it is carried out in ordinary outpatient clinics without
low IQ as an exclusion criterion. In mental health re-
search most outcome studies have been conducted
under controlled experimental conditions with strict
sample control selection [43]. This limits the external
validity of the results. The methodological strength of
this study is also the main limitation. In an ordinary out-
patient clinic with an unselected patient population it is
difficult to obtain information about the reason for
dropout, an exact overview of the number of eligible
patients, therapist competence and caseload, type of
intervention and other potential relevant factors. In our
study this could potentially have biased the sample due
to attrition. If we had collected these data, the results
could to some degree have been statistically corrected
for these factors.
Clinical implications
The main clinical implications of the present study are
that IQ moderates outcome as measured with CGAS
and that patients with the highest initial HoNOSCA
scores show the greatest improvements. These results
are potentially important as background information
when interpreting changes in CGAS and HoNOSCA
scores in ordinary clinical practice.
In spite of the findings that low IQ is a risk factor for
mental health disorders [6-10], most intervention studies
use IQ< 80 as an exclusion criterion [44-46]. In a psy-
chodynamic psychotherapy study on child internaliz-
ing disorders, the cut off for exclusion was as high as
IQ< 90 [47]. Since children and adolescents with low
IQ systematically have been excluded form most out-
come studies, there is a limited knowledge of whether
they benefit from treatment in outpatient clinics or not.
To make sure that children with low IQ receive effective
help for their mental health problems, it is particularly
important to apply systematic outcome evaluations on
this group of children and adolescents to evaluate the
effect of treatment.
Conclusion
The results from the present study showed that both
symptom load and general functioning among children
and adolescents receiving treatment in the outpatient
clinics improved. FSIQ and PIQ was a moderator of
change in general functioning and symptom load, respect-
ively. This implies that patients with higher IQ scores
had a steeper improvement slope than those with lower
scores. The patients with the highest initial symptom loadsshowed the greatest improvement, this pattern was not
found in the improvement of general functioning.
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